Bio-Path Holdings, Inc. Reports Fiscal Year 2015 Operational And Financial Results

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced operational and financial results for the year ended December 31, 2015.

Back to news